Next Article in Journal
Enteric Tuft Cells in Host-Parasite Interactions
Previous Article in Journal
Non-Assembled ORF2 Capsid Protein of Porcine Circovirus 2b Does Not Confer Protective Immunity
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pathogens
Volume 10
Issue 9
10.3390/pathogens10091162
pathogens-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Detection of CTX-M-15 Extended-Spectrum β-Lactamases Producing Escherichia coli Isolates from Colostrum and Faeces of Newborn Dairy Calves in China

by
Zhiyuan He
1,2,
Sirui Yang
1,2,
Yulin Ma
1,2,
Shuyuan Zhang
1,2 and
Zhijun Cao
1,2,*
1
Department of Animal Nutrition and Feed Science, College of Animal Science and Technology, China Agricultural University, Beijing 100193, China
2
State Key Laboratory of Animal Nutrition, Beijing Engineering Technology Research Center of Raw Milk Quality and Safety Control, Department of Animal Nutrition and Feed Science, College of Animal Science and Technology, China Agricultural University, Beijing 100193, China
*
Author to whom correspondence should be addressed.
Pathogens 2021, 10(9), 1162; https://doi.org/10.3390/pathogens10091162
Submission received: 2 August 2021 / Revised: 27 August 2021 / Accepted: 7 September 2021 / Published: 9 September 2021
Browse Figures
Versions Notes

Abstract

:
Newborn dairy calves are often colonized by multidrug-resistant (MDR) extended-spectrum β-Lactamase producing Escherichia coli (ESBL-EC), which pose significant risks to global healthcare. As the first meal of calves, the role of dairy colostrum as a potential source of MDR-E. coli has not been well-studied. Here, we report on similar antibiotic resistance patterns of E. coli strains, isolated from colostrum fed to dairy calves and their faeces. Four ESBL-EC strains from colostrum and faeces of newborn dairy calves were isolated by double-disc synergy testing and multiplex PCR. Strikingly, isolates from colostrum or faeces were found to have similar MDR profiles, showing a high resistance to cephalosporins and other conventional antibiotics. In addition, coexistence of blaCTX-M-15 and blaTEM-171 was detected on a self-transferable plasmid with a typical IncHI2 backbone. To the best of our knowledge, this is the first case reporting on ESBL-EC strains carrying blaCTX-M-15 and blaTEM-171 genes, and isolated from faeces and the colostrum stock fed to the dairy calves.

1. Introduction

The emergence and dissemination of ESBL-producing Enterobacteriaceae of animal origin are rising, and their increased prevalence has become a great challenge to veterinary practitioners around the world. E. coli is one of the most common ESBL producers in healthcare settings and often exhibits MDR [1]. As a group of hydrolytic enzymes, ESBL are mainly produced by Gram-negative bacteria conferring resistance to monobactams, penicillins, and cephalosporins.
The most common ESBL, encoded by Enterobacteriaceae, belongs to the TEM, CTX-M, SHV, or OXA family. Among them, CTX-M-type β-Lactamase genes (blaCTX-M) has spread throughout the world since its initial capture from the chromosome of Kluyvera spp. to the conjugative plasmids [2]. CTX-M ESBL encoding genes are divided into five clusters, including CTX-M-1, CTX-M-2, CTX-M-8, CTX-M-9, CTX-M-25, based on amino acid sequence identity [3,4]. In the past few years, CTX-M-15 has become one of the most dominant ESBL encoding genes, among humans and food-producing animals globally, suggesting a broad spectrum of reservoirs harboring and spreading these genes [5,6].
The increasing prevalence of highly resistant ESBL-EC, isolated from newborn animals, has become a challenge to clinical therapy. It has been linked to several external factors, including calf housing types, the environment, and postpartum calf management practices [7]. Exposure of newborn calves to antibiotic drugs may also accelerate colonisation and shedding of MDR bacteria [8]. In fact, apart from being an important source of immunoglobulins, nutrients and growth factors [9], dairy colostrum is also the origin of antimicrobial resistance genes (ARGs) or MDR bacteria for newborn calves via feeding practices [10]. Considering the importance of colostrum as a source of MDR bacteria and ARGs, investigations into its potential role as a transmission vector of ESBL-EC are crucial.
In this study, we report on four CTX-M-15 ESBL-EC isolates from faeces and colostrum fed to newborn dairy calves in China. Genotypic and phenotypic identifications of ESBL-producers were undertaken to gain a better insight into partial genomic and plasmid characterisation of the isolates.

2. Results

2.1. Antibiotic Resistance Profiles of E. coli Strains Isolated from Faeces and Colostrum Fed to Dairy Calves

Bacterial strains were isolated from colostrum fed to dairy calves and faecal samples through routine surveillance in Heilongjiang, China, in 2020. A total of 68 E. coli isolates were identified using MALDI-TOF MS system and used for further antimicrobial resistance testing trials. As shown in Figure 1, nearly all isolates were found to be tetracycline-resistant, and more than 60% of colostrum or faecal strains were resistant to ampicillin. However, a relatively high rate of susceptibility was detected towards polymyxin B (65.3%; 95% CI: 50.8, 82.1 and 63.7%; 95% CI: 47.3, 78.4, respectively). Importantly, isolates of these two groups were also showing similar resistant rate to other non β-lactams, including kanamycin (62.3%; 95% CI: 45.9, 76.3 and 67.5%; 95% CI: 49.6, 85.3), and ciprofloxacin (74.3%; 95% CI: 58.7, 88.3 and 80%; 95% CI: 63.6, 95.8). These results indicated that antibiotic resistance profiles of E. coli strains isolated from faeces and colostrum fed to dairy calves were similar.

2.2. Characterisation and Transferability of CTX-M-15 ESBL-EC

Based on the high β-lactam resistant rate, we further detected ESBL-EC using phenotypic confirmatory examinations. As a result, four strains (1557 and 1584 from colostrum, 1587 and 1591 from faeces) were recovered from the above E. coli strains (Table 1). Antimicrobial resistance testing suggested that 1557 and 1584 were resistant to all antimicrobial agents, but still susceptible to meropenem (Table 2). The presence of blaCTX-M-15 was also verified by ESBL genotype specific PCR amplification and confirmed by sequencing. As shown in Figure 2, all these four isolates carried blaCTX-M-15 and blaTEM-171 genes. Conjugation assays indicated that plasmids of strains 1557, 1584, 1587, and 1591 were transferable to E. coli strain J53 at a frequency of 5.58 × 10−4, 1.63 × 10−4, 1.78 × 10−4, and 2.58 × 10−4 per donor cell. Interestingly, the transconjugants acquired the major β-lactam resistances of their corresponding donors, but were susceptible to tetracycline, trimethoprim-sulfamethoxazole, meropenem, kanamycin, and ciprofloxacin (Table 2), which implied that the β-lactamase encoding genes and the other resistance genes were on separate replicons. Interestingly, PCR amplification and sequencing demonstrated that blaCTX-M-15 and blaTEM-171 genes were also transferred to E. coli J5 simultaneously (Figure 2), indicating the possibility of the coexistence of blaCTX-M-15 and blaTEM-171 within the same plasmid.

2.3. Plasmid Based Replicon Types (PBRT)

To further detect the plasmid type mediating the horizontal gene transfer, ESBL-ECs were detected by PBRT assays to obtain specific replicon. As we can see from Figure 3, the plasmids of the above isolates shared a specific IncHI2 iterons, suggesting that the plasmid carrying blaCTX-M-15 and blaTEM-171 belongs to the incompatibility group, IncHI2.

3. Discussion

Cephalosporins and other antibiotics (aminoglycosides or tetracyclines) have been widely used in dairy farms in China for the treatment of various diseases, including diarrhea, pneumonia, and mastitis [11]. In fact, almost all calves received antimicrobial drug treatment during their first two months, especially in the pre-weaning stage. However, the ESBL-EC isolation rate from food-producing animals has increased, placing continuous pressure on global healthcare. Therefore, the occurrence and dissemination of ESBL-EC isolates with MDR profiles in dairy calves is not unexpected. However, our existing knowledge of the effects of colostrum management on antimicrobial resistance diffusion was limited. Therefore, our present study showed that calves feeding pasteurized colostrum were infected with a markedly large scale of MDR isolates, and more than 60% of all E. coli isolates recovered from dairy colostrum or faeces were MDR. In addition, low susceptibility against common β-lactams or the other drugs was observed. This observation was similar to a previous research concerning antimicrobial resistance of E. coli in Holstein pre-weaned dairy calves [12], which might be due to the existence of β-lactamase genes and clinically combined antibiotic treatment in dairy farms. Interestingly, elevated MICs of meropenem (0.15 μg/mL) were detected compared with that of recipient E. coli J53 (0.03 μg/mL), indicating a possible mutation in one of the chromosomal genes of those E. coli. To our knowledge, this was the first report on the detection of CTX-M-15 producing ESBL-EC from colostrum and faeces of dairy calves simultaneously. In fact, infections of those ESBL-EC strains were closely linked to a high incidence rate of calf diarrhea. The cases were even worse in newborn dairy calves due to the limited drug selection and their poor immunity. Indeed, urgent efforts should be taken to reinforce infection control measures. Nowadays, biological treatments are being used to minimize the negative effects of ARGs or bacteria in milk, including heat treatment or ion catalysis [13,14]. Among them, pasteurization is frequently used to decrease microbial contamination and induce antibiotics reduction. However, more effective tools are essential for evaluating the effectiveness of those methods.
In this study, four E. coli isolates from calves were detected as resistant to at least five β-lactams. The same phenomena was also found in tetracyclines, fluoroquinolones, aminoglycosides, and carbapenems. Pre-weaned calves were the most susceptible groups to ESBL-EC or the other kinds of MDR bacteria. Indeed, various β-Lactamases resistant genes appeared in lactating cattle were also detected in heifers [15]. Our results showed that blaCTX-M-15 and blaTEM-171 genes were detected simultaneously in isolates from faeces of calves and the colostrum fed to calves, which was similar to the detection of CTX-M-15 E. coli from cattle or other food-producing animals in East Asia and a national resistance surveillance study of ESBL-EC [5,16]. It was known that, plasmid-mediated horizontal transfer of resistant genes in commensal E. coli accelerated the spread of resistance, especially CTX-M-type β-lactamase genes [17,18]. This study detected the existence of the conjugatable plasmid IncHI2 with blaCTX-M-15 and blaTEM-171 genes in four ESBL-ECs, which were isolated from faeces of calves, as well as the colostrum that was used to feed calves in the farm. Similar plasmid was previously detected in ST114- E. cloacae isolates, mostly carrying blaCTX-M-15 gene [19]. Importantly, our study observed a relatively high transfer frequency from donors to E. coli, indicating the great potential of interspecies transfer of blaCTX-M-15. Therefore, further surveillance and plasmid characterization were needed to monitor the epidemic spread of such blaCTX-M-15-carrying IncHI2 plasmids among Enterobacteriaceae. Notably, IncHI2 was the most prevalent plasmid type in this study. The existence of complicated resistant gene types could contribute to the large-scale diffusion of plasmids, which mediated better survival in the selective pressure.
It was worth noting that the antimicrobial susceptibility profiles of those strains had been systematically analysed, but relatively small samples limited this research, particularly given the large reserve of heifers in China. In our current study, colostrum samples were collected aseptically to minimize the impacts of environmental contamination and all meconium samples of those calves were also screened for negative ESBL genes to eliminate the influence of maternal factors. Therefore, this study reflected the real impact of colostrum feeding practice and the transmission process from colostrum to faeces on the colonization of ESBL-EC in dairy calves. On this basis, environmental disinfection in the delivery rooms and calf hutches needed to be firmly enforced and revised in pasture. More importantly, control measures of pasteurized colostrum may have an immediate impact by interrupting chains of transmission in newborn dairy calves. Colostrum was the first meal of newborn dairy calves and a vital source of available passive immunity. Our results demonstrated that colostrum was a possible transmission vector of CTX-M-15 ESBL-EC exposure to newborn dairy calves. Therefore, further studies are required to evaluate the effects of feeding colostrum on the prevalence of ESBL-EC and IncHI2 plasmid among dairy farms in China. In summary, this study was an observation experiment on the epidemics of CTX-M-15 ESBL-EC among newborn dairy calves, suggesting the possible spreading chain in communities via colostrum feeding.

4. Materials and Methods

4.1. E. coli Cells and Reagents

J53 E. coli cells were purchased from Transgen company (Beijing, China). Unless otherwise noted, strains were grown in Luria-Bertani broth (LB, Qingdao Hope Bio-technology) or on LB agar plates at 37 °C for 18 h. MacConkey agar quantities were obtained from Luqiao (Beijing, China). Antimicrobial drug standards were purchased from Solarbio (Beijing, China). Kirby-Bauer disks for drug sensitivity test were obtained from Hangzhou Microbial reagent company (Hangzhou, China).

4.2. The Farm and Sample Collection

The samples used in this study were collected from a conventional dairy farm, located in the south of Heilongjiang Province in 2020. The farm raised about 3173 heifers and 4945 adult cows of Holstein. It represent the typical dairy production practices of China, where β-lactams are regularly used to treat calf diarrhea, including penicillin and ceftiofur. The sampling protocols were reviewed and approved by the Beijing Association for Science and Technology (ID no. SYXK, 2016-0008). Colostrum samples were randomly collected from 10 healthy Holstein dairy cows 2 h postpartum aseptically, and then pasteurized according to colostrum management method of farm, which were treated at 62 °C for 30 min in 50 mL centrifuge using water bath (HerryTech, Shanghai, China). The samples were stored in the farm freezer until they were used for subsequent bacterial isolation. Touching anus was used to increase meconium excretion, and then faecal samples were randomly collected from 30 individual newborn female calves (0–14 d) with clinical diarrhea from September 2020 to October 2020. All calves were similar in physical conditions, and were fed 4 L of maternal colostrum from certain milking cows during the first 2 h of their lives. Calves were individually arranged in calf hutches to avoid direct contact and bucket fed 4–6 L of raw milk (mixture of raw milk and waste milk) daily during the first month of age. Non-medicated calf starter (25.6% crude protein, 4% crude fat, 24.5% neutral detergent fiber) was offered along with raw milk from day 3 until weaning. Dedicated equipment and sterile gloves were used for rectal fecal sample collection to prevent cross-contamination. No calves received therapeutic antibiotic treatment during the trial.

4.3. Bacterial Isolation and Identification

A quantity of 1 mL colostrum sample or 1 g calf faeces was diluted in 9 mL of LB before incubated overnight at 37 °C and then streaked onto MacConkey agar plates using the pure culture law. The suspected colonies with red colour in Maconkey agar plates were confirmed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) (BrukerDaltonik GmbH, Bremen, Germany). The common genes encoding ESBL were screened by PCR as described previously with minor revisions and confirmed by sequencing [20]. Confirmed isolates were stored in LB containing 30% glycerol at −80 °C for further analysis. All experimental protocols were approved by the institutional ethics committees of China Agricultural University (Approval IDs: XXMB-2012-03-01-1, XXMBB-2012-03-15-1).

4.4. Antimicrobial Susceptibility Testing

Antibiotic susceptibility testing was carried out using the VITEK 2 compact system (bioMérieux, Marcy-l’Étoile, France). The minimum inhibitory concentrations (MICs) results of 10 antibiotics (tetracycline, trimethoprim-sulfamethoxazole, amoxicillin-clavulanate, cefepime, aztreonam, meropenem, ampicillin, cefotaxime, kanamycin, ciprofloxacin) were determined using the agar dilution method, according to the breakpoints and interpreted criteria of the Clinical and Laboratory Standards Institute (CLSI) guidelines [21] and the EUCAST guidelines (http://www.eucast.org, accessed on 1 January 2021). Reference strain E. coli ATCC 25,922 (Tianhe, Hangzhou, China) was used as the quality control strain.

4.5. Phenotypic Screening of ESBL-Producing E. coli

All E. coli isolates were screened for the phenotypic identification of ESBL-producers on MacConkey agar containing cefotaxime (2 mg/L), followed by confirmation using double-disc synergy testing, in accordance with CLSI recommendations. Isolates were determined to be positive when the clear zone inhibition of ceftazidime plus clavulanic acid, or cefotaxime plus clavulanic acid, was at least 5 mm larger than their respective single discs [22].

4.6. Conjugation Experiment

The horizontal transferability of CTX-M-15 was tested using conjugation assay by broth and filter mating with E. coli J53 (azide-resistant) as the recipient strain. The transconjugants were selected on LB agar plates containing 2 mg/L cefotaxime and 100 mg/L sodium azide only after incubating donor and recipient organisms in 4 mL LB for 18 h. The acquired drug resistances of transconjugants were assessed by antimicrobial susceptibility testing. Common ESBL genes in the transconjugants were confirmed by PCR amplification.

4.7. Plasmid Based Replicon Types (PBRT)

A Multiplex PCR was adopted to identify specific replicon types of plasmids based on the previously established means [23,24]. PBRT products with similar band profiles were determined to be the same plasmid types.

4.8. Statistical Analysis

Statistical analysis was conducted using Graphpad prism 5 (version 5.2.1350.0) and SPASS (version 19.0) software. Data were presented as Mean ± SD. All experimental data were representative of three independent experiments with similar results.

5. Conclusions

In conclusion, this study characterised four CTX-M-15 ESBLs-EC strains carrying MDR properties. The study demonstrated the isolation and characterisation of the conjugatable plasmid IncHI2 with blaCTX-M-15 and blaTEM-171 genes from faeces of calves and the colostrum that was used to feed calves in the farm. Our findings demonstrate that the plasmid is self-transmissible to other Enterobacterales, thereby making them intractable to antibiotics. Further, the study highlights the urgent need to control and monitor the potential spread of such conjugatable plasmid in dairy farms.

Author Contributions

Conceptualisation, S.Z. and Z.H.; methodology, S.Z. and Z.C.; investigation, S.Y., Y.M. and S.Z.; date curation, S.Y. and Z.H.; writing-original draft preparation, S.Y. and Z.H.; writing-review and editing, Z.H. and Z.C.; supervision, Z.C.; funding acquisition, Z.C. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by grants from the National Key research and Program of China, grant number: 2018YFD0501600. The funders had no role in the study design, data collection and analysis, or in deciding to prepare or publish this manuscript.

Institutional Review Board Statement

The study was conducted according to the Declaration of the Beijing Association for Science and Technology (ID no. SYXK, 2016-0008), and approved by the institutional ethics committees of China Agricultural University (Approval IDs: XXMB-2012-03-01-1, XXMBB-2012-03-15-1).

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were generated or analysed in support of this research.

Acknowledgments

The authors thank Yang Wang from College of Veterinary Medicine, China Agricultural University, and the local ranch staff for their generous assistance.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Paterson, D.L. Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Med. 2006, 34, S20–S28. [Google Scholar] [CrossRef] [PubMed]
  2. Rossolini, G.M.; D’Andrea, M.M.; Mugnaioli, C. The spread of CTX-M-type extended-spectrum beta-lactamases. Clin. Microbiol. Infect. 2008, 14 (Suppl. S1), 33–41. [Google Scholar] [CrossRef] [Green Version]
  3. Bradford, P.A. Extended-spectrum beta-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 2001, 14, 933–951. [Google Scholar] [CrossRef] [Green Version]
  4. Bonnet, R. Growing group of extended-spectrum beta-lactamases: The CTX-M enzymes. Antimicrob. Agents Chemother. 2004, 48, 1–14. [Google Scholar] [CrossRef] [Green Version]
  5. Liu, H.; Wang, Y.; Wang, G.; Xing, Q.; Shao, L.; Dong, X.; Sai, L.; Liu, Y.; Ma, L. The prevalence of Escherichia coli strains with extended spectrum beta-lactamases isolated in China. Front. Microbiol. 2015, 6, 335. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Xu, G.; An, W.; Wang, H.; Zhang, X. Prevalence and characteristics of extended-spectrum beta-lactamase genes in Escherichia coli isolated from piglets with post-weaning diarrhea in Heilongjiang province, China. Front. Microbiol. 2015, 6, 1103. [Google Scholar] [CrossRef]
  7. Pereira, R.V.; Siler, J.D.; Ng, J.C.; Davis, M.A.; Warnick, L.D. Effect of preweaned dairy calf housing system on antimicrobial resistance in commensal Escherichia coli. J. Dairy Sci. 2014, 97, 7633–7643. [Google Scholar] [CrossRef] [Green Version]
  8. Berge, A.C.; Moore, D.A.; Sischo, W.M. Field trial evaluating the influence of prophylactic and therapeutic antimicrobial administration on antimicrobial resistance of fecal Escherichia coli in dairy calves. Appl. Environ. Microbiol. 2006, 72, 3872–3878. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Playford, R.J.; Weiser, M.J. Bovine Colostrum: Its Constituents and Uses. Nutrients 2021, 13, 265. [Google Scholar] [CrossRef]
  10. Tetens, J.L.; Billerbeck, S.; Schwenker, J.A.; Holzel, C.S. Short communication: Selection of extended-spectrum beta-lactamase-producing Escherichia coli in dairy calves associated with antibiotic dry cow therapy—A cohort study. J. Dairy Sci. 2019, 102, 11449–11452. [Google Scholar] [CrossRef] [PubMed]
  11. Ali, T.; Ur, R.S.; Zhang, L.; Shahid, M.; Zhang, S.; Liu, G.; Gao, J.; Han, B. ESBL-Producing Escherichia coli from Cows Suffering Mastitis in China Contain Clinical Class 1 Integrons with CTX-M Linked to ISCR1. Front. Microbiol. 2016, 7, 1931. [Google Scholar] [CrossRef]
  12. Afema, J.A.; Davis, M.A.; Sischo, W.M. Antimicrobial use policy change in pre-weaned dairy calves and its impact on antimicrobial resistance in commensal Escherichia coli: A cross sectional and ecological study. BMC Microbiol. 2019, 19, 217. [Google Scholar] [CrossRef]
  13. Roca, M.; Villegas, L.; Kortabitarte, M.L.; Althaus, R.L.; Molina, M.P. Effect of heat treatments on stability of beta-lactams in milk. J. Dairy Sci. 2011, 94, 1155–1164. [Google Scholar] [CrossRef] [PubMed]
  14. Li, X.; Zheng, W.; Machesky, M.L.; Yates, S.R.; Katterhenry, M. Degradation kinetics and mechanism of antibiotic ceftiofur in recycled water derived from a beef farm. J. Agric. Food Chem. 2011, 59, 10176–10181. [Google Scholar] [CrossRef] [Green Version]
  15. Kyselkova, M.; Jirout, J.; Vrchotova, N.; Schmitt, H.; Elhottova, D. Spread of tetracycline resistance genes at a conventional dairy farm. Front. Microbiol. 2015, 6, 536. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Yu, T.; He, T.; Yao, H.; Zhang, J.B.; Li, X.N.; Zhang, R.M.; Wang, G.Q. Prevalence of 16S rRNA Methylase Gene rmtB Among Escherichia coli Isolated from Bovine Mastitis in Ningxia, China. Foodborne Pathog. Dis. 2015, 12, 770–777. [Google Scholar] [CrossRef]
  17. D’Andrea, M.M.; Arena, F.; Pallecchi, L.; Rossolini, G.M. CTX-M-type beta-lactamases: A successful story of antibiotic resistance. Int. J. Med. Microbiol. 2013, 303, 305–317. [Google Scholar] [CrossRef] [PubMed]
  18. Roberts, M.C. Update on acquired tetracycline resistance genes. FEMS Microbiol. Lett. 2005, 245, 195–203. [Google Scholar] [CrossRef]
  19. Haenni, M.; Saras, E.; Ponsin, C.; Dahmen, S.; Petitjean, M.; Hocquet, D.; Madec, J.Y. High prevalence of international ESBL CTX-M-15-producing Enterobacter cloacae ST114 clone in animals. J. Antimicrob. Chemother. 2016, 71, 1497–1500. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Dallenne, C.; Da, C.A.; Decre, D.; Favier, C.; Arlet, G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J. Antimicrob. Chemother. 2010, 65, 490–495. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. CLSI. Performance Standards for Antimicrobial Susceptibility Testing, 26th ed.; CLSI Supplement M100S; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2016. [Google Scholar]
  22. Dingle, T.; Sei, K.; Mitchell, S.L.; Humphries, R.M.; Koeth, L.; Ambler, J.; Castanheira, M.; Hindler, J.A. CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests. J. Clin. Microbiol. 2018, 56, e01934-17. [Google Scholar]
  23. Carattoli, A.; Bertini, A.; Villa, L.; Falbo, V.; Hopkins, K.L.; Threlfall, E.J. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 2005, 63, 219–228. [Google Scholar] [CrossRef] [PubMed]
  24. Johnson, T.J.; Bielak, E.M.; Fortini, D.; Hansen, L.H.; Hasman, H.; Debroy, C.; Nolan, L.K.; Carattoli, A. Expansion of the IncX plasmid family for improved identification and typing of novel plasmids in drug-resistant Enterobacteriaceae. Plasmid 2012, 68, 43–50. [Google Scholar] [CrossRef] [PubMed]
Pathogens 10 01162 g001 550
Figure 1. Distribution of antibiotic resistance patterns of E. coli strains isolated from faeces and colostrum fed to dairy calves. The proportion of isolates microbiologically resistant to different antimicrobials in the different production systems based on phenotypic characterisation by VITEK method. Five commonly used antimicrobial agents in human clinic and/or animal husbandry are detected in this study. R, resistant; I, intermediate; S, susceptible.
Figure 1. Distribution of antibiotic resistance patterns of E. coli strains isolated from faeces and colostrum fed to dairy calves. The proportion of isolates microbiologically resistant to different antimicrobials in the different production systems based on phenotypic characterisation by VITEK method. Five commonly used antimicrobial agents in human clinic and/or animal husbandry are detected in this study. R, resistant; I, intermediate; S, susceptible.
Pathogens 10 01162 g001
Pathogens 10 01162 g002 550
Figure 2. Detection of ESBL genes in E. coli isolates. PCR products were separated on 1% agarose gel. M: 100–5000 bp DNA marker; 1: blaTEM positive isolate; 2: blaCTX-M positive isolate; 3: 1557 isolate; 4: 1584 isolate; 5: 1587 isolate; 6: 1591 isolate; 7: T-1557 isolate; 8: T-1584 isolate; 9: T-1587 isolate; 10: T-1591 isolate.
Figure 2. Detection of ESBL genes in E. coli isolates. PCR products were separated on 1% agarose gel. M: 100–5000 bp DNA marker; 1: blaTEM positive isolate; 2: blaCTX-M positive isolate; 3: 1557 isolate; 4: 1584 isolate; 5: 1587 isolate; 6: 1591 isolate; 7: T-1557 isolate; 8: T-1584 isolate; 9: T-1587 isolate; 10: T-1591 isolate.
Pathogens 10 01162 g002
Pathogens 10 01162 g003 550
Figure 3. Detection of Inc types of ESBL-producing E. coli plasmids according to previous publications of ESBL. PCR products were separated onto 1% agarose gel. M: 100–5000 bp DNA marker; 1: 1557 isolate; 2: 1584 isolate; 3: 1587 isolate; 4: 1591 isolate; 5: T-1557 isolate; 6: T-1584 isolate; 7: T-1587 isolate; 8: T-1591 isolate; 9: IncHI2 positive control isolate.
Figure 3. Detection of Inc types of ESBL-producing E. coli plasmids according to previous publications of ESBL. PCR products were separated onto 1% agarose gel. M: 100–5000 bp DNA marker; 1: 1557 isolate; 2: 1584 isolate; 3: 1587 isolate; 4: 1591 isolate; 5: T-1557 isolate; 6: T-1584 isolate; 7: T-1587 isolate; 8: T-1591 isolate; 9: IncHI2 positive control isolate.
Pathogens 10 01162 g003
Table
Table 1. Double Disc Synergy Test (DDST) for confirmation of ESBL-producing E. coli.
Table 1. Double Disc Synergy Test (DDST) for confirmation of ESBL-producing E. coli.
Clear Zone Inhibition 1Diameter (mm) 2
1557158415871591
CTX13111212
CTX/CA23192018
CAZ1812128
CAZ/CA25182415
1 Antimicrobial agents are abbreviated as follows: Cefotaxime (CTX), Cefotaxime plus Clavulanic acid (CTX/CA), Ceftazidime (CAZ), Ceftazidime plus Clavulanic acid (CTX/CA). 2 The test was considered to be positive when the zone of inhibition of cefotaxime plus clavulanic acid or ceftazidime plus clavulanic acid was >5 mm compared to their respective single discs.
Table
Table 2. Antimicrobial susceptibility profiles of different bacterial hosts carrying blaCTX-M and blaTEM-positive plasmids, E. coli-J53 transconjugants and the E. coli-J53 recipient.
Table 2. Antimicrobial susceptibility profiles of different bacterial hosts carrying blaCTX-M and blaTEM-positive plasmids, E. coli-J53 transconjugants and the E. coli-J53 recipient.
Strains 1MICs (μg/mL) 2
TETTESAMCCEPAZTMPNAMPCTXKANCIP
15571288/160128/6416>640.15>256>256102464
T-155711/10128/648160.15>256>2560.250.25
15845128/320128/6416320.15>256>25664128
T-158411/10128/64880.15>256>2560.250.25
15872568/160128/6416>640.15>256>256256128
T-158711/10128/648160.15>256>2560.250.25
15912568/32064/3216>640.15>256>25625664
T-159111/1064/328160.15>256>2560.250.25
J5311/101/0.50.2510.0320.250.250.25
1 T-1557, T-1584, T-1587 and T-1591 represent the transconjugations of E. coli 1557, E. coli 1584, E. coli 1587 and E. coli 1591. 2 MIC, minimum inhibitory concentration. Antimicrobial agents are abbreviated as follows: Tetracycline (TET), Trimethoprim-sulfamethoxazole (TES), Amoxicillin-clavulanate (AMC), Cefepime (CEP), Aztreonam (AZT), Meropenem (MPN), Ampicillin (AMP), Cefotaxime (CTX), Kanamycin (KAN), Ciprofloxacin (CIP). Data are summarised from three different experiments.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

He, Z.; Yang, S.; Ma, Y.; Zhang, S.; Cao, Z. Detection of CTX-M-15 Extended-Spectrum β-Lactamases Producing Escherichia coli Isolates from Colostrum and Faeces of Newborn Dairy Calves in China. Pathogens 2021, 10, 1162. https://doi.org/10.3390/pathogens10091162

AMA Style

He Z, Yang S, Ma Y, Zhang S, Cao Z. Detection of CTX-M-15 Extended-Spectrum β-Lactamases Producing Escherichia coli Isolates from Colostrum and Faeces of Newborn Dairy Calves in China. Pathogens. 2021; 10(9):1162. https://doi.org/10.3390/pathogens10091162

Chicago/Turabian Style

He, Zhiyuan, Sirui Yang, Yulin Ma, Shuyuan Zhang, and Zhijun Cao. 2021. "Detection of CTX-M-15 Extended-Spectrum β-Lactamases Producing Escherichia coli Isolates from Colostrum and Faeces of Newborn Dairy Calves in China" Pathogens 10, no. 9: 1162. https://doi.org/10.3390/pathogens10091162

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop